The role of lycopene for the amelioration of glycaemic status and peripheral antioxidant capacity among the Type II diabetes mellitus patients: a case–control study

The use of lycopene as a complementary medicine for Type II diabetes mellitus (T2DM) is limited and controversial. This study evaluated the effect of lycopene intake on the changes of glycaemic status and antioxidant capacity among the T2DM patients.

File Type: 1943515
Categories: By Others, Lycopene
Tags: Metabolic Health

Continue reading

Lycored Debuts New VAS Technology at SupplySide Global

BRANCHBURG, N.J., Oct. 29, 2025 /PRNewswire/ — Lycored, the global leader in naturally derived carotenoids for the food, beverage and dietary supplement market, is expanding its ingredient capabilities with the...

Dafna Cohen-Asher Named CEO of ADAMA’s Lycored

BEIJING and TEL AVIV, Israel, Oct. 22, 2025 /PRNewswire/ — ADAMA (SZSE: 000553), a global leader in crop protection, has announced the appointment of Dafna Cohen-Asher as Chief Executive Officer of Lycored,...

September 2025 Newsletter – Hot Trend Alert: Nature Based 🍃Science Backed🔬

 Lycored Emulsions You’ve heard it this year; it’s time for your product’s colors to shine through their natural composition. In that context, it looks like our emulsion solutions come at...

We're here for you

Interested in speaking directly with a member of our team?
Click below to get in touch.

Contact us